Recommended Anti-Tuberculosis Treatment (ATT) Doses for Drug-Susceptible Tuberculosis
For drug-susceptible tuberculosis, the recommended daily doses for adults are: isoniazid 5 mg/kg (typically 300 mg), rifampin 10 mg/kg (typically 600 mg), pyrazinamide 15-30 mg/kg (maximum 2g), and ethambutol 15-25 mg/kg. 1, 2
First-Line Drug Dosing for Adults
Daily Dosing (Preferred Regimen)
- Isoniazid: 5 mg/kg (typically 300 mg) daily 1
- Rifampin: 10 mg/kg (typically 600 mg) daily 1
- Pyrazinamide: 15-30 mg/kg daily (maximum 2g) 2
- Ethambutol: 15-25 mg/kg daily 1
- Pyridoxine (vitamin B6): 25-50 mg daily should be given with isoniazid to all persons at risk of neuropathy (pregnant women, breastfeeding infants, persons with HIV, diabetes, alcoholism, malnutrition, chronic renal failure, or advanced age) 1
Intermittent Dosing Options
Twice-weekly dosing:
Thrice-weekly dosing (only for non-HIV patients at low risk of relapse):
First-Line Drug Dosing for Children
Daily Dosing (Preferred Regimen)
- Isoniazid: 10-15 mg/kg daily 1
- Rifampin: 10-20 mg/kg daily 1
- Pyrazinamide: 35 (30-40) mg/kg daily 1
- Ethambutol: 20 (15-25) mg/kg daily 1
Intermittent Dosing Options
- Twice-weekly dosing:
Second-Line Drug Dosing
Fluoroquinolones
Injectable Agents
- Streptomycin: 15 mg/kg daily (maximum 1g) for adults 1
- Amikacin/Kanamycin: 15 mg/kg daily for adults 1
- Capreomycin: 15 mg/kg daily for adults 1
Other Second-Line Drugs
- Cycloserine: 10-15 mg/kg total (usually 250-500 mg once or twice daily) for adults 1
- Ethionamide: 15-20 mg/kg total (usually 250-500 mg once or twice daily) for adults 1
- Para-aminosalicylic acid: 8-12 g total (usually 4000 mg 2-3 times daily) for adults 1
Important Clinical Considerations
- For obese patients (>20% above ideal body weight), dosing based on ideal body weight may be preferred for initial doses 1
- Therapeutic drug monitoring should be considered for obese patients 1
- Rifabutin dose may need adjustment when used with protease inhibitors or non-nucleoside reverse transcriptase inhibitors 1
- For patients with peripheral neuropathy, increase pyridoxine dose to 100 mg/day 1
- Patients with decreased renal function may require the 15 mg/kg dose of injectable agents to be given only 3 times weekly to allow for drug clearance 1
- Children with HIV infection and/or low body weight (4-7 kg) may require higher rifampin doses due to lower drug exposure and higher risk of unfavorable outcomes 3
- Ethambutol should be used with caution in children whose visual acuity cannot be monitored 1
Standard Treatment Regimen
- The established standard regimen consists of an initial phase (first 2 months) with daily rifampin, isoniazid, pyrazinamide, and ethambutol, followed by a continuation phase (next 4 months) with daily rifampin and isoniazid 4
- Ethambutol can be omitted in the initial phase for patients with a low risk of isoniazid resistance (less than 4% primary resistance in the community) 4, 5
- For TB meningitis and CNS tuberculosis, treatment should be extended to 12 months total 4, 5
By following these dosing recommendations and considering patient-specific factors, optimal treatment outcomes can be achieved while minimizing adverse effects in patients with drug-susceptible tuberculosis.